Sector report: Healthcare

The health sector has been going through various technological shifts in the context of an increasingly digitised, mobile and data-driven world. This trend predates the covid-19 pandemic and the nearly universal lockdowns of last year but it was undoubtedly accelerated by it. It is the life sciences sector that has developed in record time effective vaccines that have given hope that the world will be back to normal soon.

When it comes to innovation in drug discovery, medical devices and the digitisation of health services, the role of general economic conditions and, particularly, low interest rates cannot be overstated. We had been living in a low interest rate environment since the end of the Global Financial Crisis in 2008 and with the shock of the Covid-19 pandemic, rates have hit a new record low. The benefits for life sciences sectors stemming from cheap credit are rather simple to comprehend –…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?